[HTML][HTML] Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study

A Pandit, N Bhalani, BLS Bhushan, P Koradia… - International Journal of …, 2021 - Elsevier
Objective To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b)
along with the standard of care (SOC) in subjects with moderate COVID-19. Methods In this …

[HTML][HTML] Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India

…, R Gupta, VP Meena, S Vig, A Pandit… - Indian Journal of …, 2020 - journals.lww.com
Methods: This was a prospective, single-centre collection of data regarding epidemiological,
demographic, clinical and laboratory parameters, management and outcome of COVID-19 …

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

…, S Mahajan, T Dwivedi, B Sahoo, A Pandit… - Journal of Infection and …, 2021 - Elsevier
Introduction Ivermectin is an antiparasitic drug which has in-vitro efficacy in reducing severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral load. Hence, Ivermectin is …

[HTML][HTML] Effect of meditation and breathing exercises on the well-being of patients with SARS-CoV-2 infection under institutional isolation: a randomized control trial

K Mahendru, A Pandit, V Singh… - Indian journal of …, 2021 - ncbi.nlm.nih.gov
Objectives: The corona virus disease-19 (COVID-19) pandemic has affected every domain
of human health be it physical or mental. The uncertainty of disease progression in patients …

[HTML][HTML] Concerns of health-care professionals managing COVID patients under institutional isolation during COVID-19 pandemic in India: A descriptive cross …

…, N Singh, N Haokip, S Bhopale, A Pandit… - Indian Journal of …, 2020 - ncbi.nlm.nih.gov
Objective: Health-care professionals (HCPs) are the frontline warriors in the time of this
uncertain and unpredictable crisis of COVID. They face many challenges while caring for these …

[HTML][HTML] Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort study

…, B Ratre, P Sirohiya, N Gupta, R Garg, A Pandit… - Lung India, 2022 - journals.lww.com
Background: The “second wave” of the COVID-19 pandemic hit India from early April 2021
to June 2021. We describe the clinical features, treatment trends, and baseline laboratory …

[HTML][HTML] Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous?-A retrospective cohort study

…, BK Ratre, R Singh, B Kumar, S Vig, A Pandit… - Lung India, 2022 - journals.lww.com
Background: Hypoxia in patients with COVID-19 is one of the strongest predictors of
mortality. Silent hypoxia is characterised by the presence of hypoxia without dyspnoea. Silent …

Surviving COVID-19 is half the battle; living life with perceived stigma is other half: A cross-sectional study

…, N Haokip, S Singh, A Pandit… - Indian Journal of …, 2021 - journals.sagepub.com
Background: Year 2020 started with global health crisis known as COVID-19. In lack of
established tools and management protocols, COVID-19 had become breeding ground for fear …

[HTML][HTML] Effect of palliative bronchoscopic interventions on symptom burden in patients with central airway narrowing: A retrospective review

A Pandit, N Gupta, V Kumar, SJ Bharati… - Indian Journal of …, 2019 - ncbi.nlm.nih.gov
Materials and Methods: Detailed records of 105 patients with CAO were retrospectively
studied. The Numerical Rating Scale (NRS) score for cough and dyspnea before and after the …

[HTML][HTML] A correlation analysis of peripheral oxygen saturation and arterial oxygen saturation among COVID-19 patients

…, JK Meena, R Singh, B k Ratre, B Kumar, A Pandit… - Cureus, 2022 - ncbi.nlm.nih.gov
Methods In this observational study, SpO 2 was recorded and arterial blood gas analysis was
performed among 70 COVID-19 patients presenting on room air (FiO 2= 0.21). SaO 2 and …